Voyage Biomedical
Developing a medical device to reduce brain damage from ischemic events
Developing a medical device to reduce brain damage from ischemic events
Voyage Biomedical is a promising startup with a clear focus on revolutionizing the treatment of cardiac arrests. The company is developing a medical device aimed at reducing brain damage from ischemic events, which has the potential to be a game-changer in the field. Affiliated with UCSF and UC Berkeley, Voyage Biomedical benefits from strong partnerships with reputable institutions. Based in the United States, it has positioned itself in a hub of innovation and healthcare excellence. While specific details about their last investment are not available, the company's dedication to addressing a critical medical need and its strategic partnerships make it a compelling investment opportunity for venture capitalists.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Pre Seed Round | $150.00K | 3 |
|
20 Apr 2019 |
No recent news or press coverage available for Voyage Biomedical.
We care about your data, and we'd love to use cookies make your experience better.
